Insider Transactions in Q3 2022 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-3.62%
|
$176,000
$11.2 P/Share
|
|
Sep 29
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.75%
|
$16,000
$1.06 P/Share
|
|
Sep 19
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.56%
|
-
|
|
Sep 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.84%
|
$130,000
$13.66 P/Share
|
|
Sep 15
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.6%
|
$10,000
$2.22 P/Share
|
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$25,000
$10.5 P/Share
|
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,566
-3.22%
|
$365,660
$10.34 P/Share
|
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.16%
|
-
|
|
Sep 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.22%
|
$62,500
$2.48 P/Share
|
|
Aug 17
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.55%
|
-
|
|
Aug 16
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
30,000
-23.3%
|
$360,000
$12.61 P/Share
|
|
Aug 16
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+16.26%
|
$50,000
$2.22 P/Share
|
|
Aug 16
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-5.14%
|
$192,000
$12.6 P/Share
|
|
Aug 16
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.75%
|
$16,000
$1.06 P/Share
|
|
Aug 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.59%
|
$7,356
$12.96 P/Share
|
|
Aug 15
2022
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,065
-0.18%
|
$12,780
$12.96 P/Share
|
|
Aug 15
2022
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,453
-0.7%
|
$17,436
$12.96 P/Share
|
|
Aug 15
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,751
-1.06%
|
$69,012
$12.96 P/Share
|
|
Aug 04
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$22,500
$9.45 P/Share
|
|
Aug 04
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Aug 04
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,825
-3.29%
|
$331,425
$9.49 P/Share
|
|
Aug 04
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.2%
|
-
|
|
Aug 04
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.28%
|
$62,500
$2.48 P/Share
|
|
Jul 19
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.55%
|
-
|
|
Jul 08
2022
|
Zavain Dar Director |
BUY
Other acquisition or disposition
|
Direct |
2,420
+10.53%
|
-
|
|
Jul 07
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$22,500
$9.07 P/Share
|
|
Jul 07
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Jul 07
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,114
-3.39%
|
$334,026
$9.06 P/Share
|
|
Jul 07
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.27%
|
-
|
|
Jul 07
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.4%
|
$62,500
$2.48 P/Share
|
|
Jul 01
2022
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,224
+6.6%
|
-
|
|
Jul 01
2022
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,186
+0.02%
|
-
|
|
Jul 01
2022
|
Zachary Bogue Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,260
+23.9%
|
-
|
|
Jul 01
2022
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,409
+0.23%
|
-
|
|
Jul 01
2022
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,631
+1.03%
|
-
|